Bovine respiratory syncytial virus infection: Immunopathogenic mechanisms

Animal Health Research Reviews

Volumn 8, Issue 2, 1996, Pages 207-213

  Gershwin, Laurel J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bovine respiratory syncytial virus; IgE; immunomodulation; vaccine

Indexed keywords

IMMUNOLOGIC FACTOR; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; CATTLE; CATTLE DISEASE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VACCINATION; VIROLOGY; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; HOST-PATHOGEN INTERACTIONS; IMMUNOLOGIC FACTORS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; VACCINATION;

EID: 41249088135     PISSN: 14662523     EISSN: 14752654     Source Type: Journal    
DOI: 10.1017/S1466252307001405     Document Type: Review

References (47)

1. Antonis AF, Schrijver RS, Daus F, Steverink PJ, Stockhofe N, Hensen EJ, Langedijk JP and van der Most RG (2003). Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis. Journal of Virology 77: 12067-12073.
2. Barends M, Van Oosten M, De Rond CG, Dormans JA, Osterhaus AD, Neijens HJ and Kimman TG (2004). Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation. Journal of Infectious Diseases 189: 1866-1872.
3. Becker Y (2006). Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 33: 235-252.
4. Berghaus LJ, Corbeil LB, Berghaus RD, Kalina WV, Kimball RA and Gershwin LJ (2006). Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses. Vaccine 24: 6018-6027.
5. Bharadwaj AS, Bewtra AK and Agrawal DK (2007). Dendritic cells in allergic airway inflammation. Canadian Journal of Physiology and Pharmacology 85: 686-699.
6. Ciszewski DK, Baker JC, Slocombe RF, Reindel JF, Haines DM and Clark EG (1991). Experimental reproduction of respiratory tract disease with bovine respiratory syncytial virus. Veterinary Microbiology 28: 39-60.
7. Corbeil LB, Arnold KF, Kimball R, Berghaus L and Gershwin LJ (2006). Specificity of IgG and IgE antibody responses to Haemophilus somnus infection of calves. Veterinary Immunology Immunopathology 113: 191-199.
8. Deplanche M, Lemaire M, Mirandette C, Bonnet M, Schelcher F and Meyer G (2007). In vivo evidence for quasispecies distributions in the bovine respiratory syncytial virus genome. Journal of General Virology 88: 1260-1265.
9. Estes DM and Brown WC (2002). Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Veterinary Immunology and Immunopathology 90: 1-10.
10. Falsey AR (2007). Respiratory syncytial virus infection in adults. Seminars in Respiratory and Critical Care Medicine 28: 171-181.
11. Gershwin LJ and Giri SN (1992). Effects of allergen challenge on plasma concentrations of prostaglandins, thromboxane B2, and histamine in calves infected with bovine respiratory syncytial virus. American Journal of Veterinary Research 53: 1670-1674.
12. Gershwin LJ, Himes SR, Dungworth DL, Giri SN, Friebertshauser KE and Camacho M (1994). Effect of bovine respiratory syncytial virus infection on hypersensitivity to inhaled Micropolyspora faeni. International Archives of Allergy and Immunology 104: 79-91.
13. Gershwin LJ, Schelegle ES, Gunther RA, Anderson ML, Woolums AR, Larochelle DR, Boyle GA, Friebertshauser KE and Singer RS (1998). A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 16: 1225-1236.
14. Gershwin LJ, Gunther RA, Anderson ML, Woolums AR, McArthur-Vaughan K, Randel KE, Boyle GA, Friebertshauser KE and McInturff PS (2000). Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and-4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves. American Journal of Veterinary Research 61: 291-298.
15. Gershwin LJ, Berghaus LJ, Arnold K, Anderson ML and Corbeil LB (2005). Immune mechanisms of pathogenetic synergy in concurrent bovine pulmonary infection with Haemophilus somnus and bovine respiratory syncytial virus. Veterinary Immunology and Immunopathology 15: 119-130.
16. Gershwin LJ, Gunther RA, Hornof WJ and Larson RF. Bovine respiratory syncytial virus infection alters pulmonary clearance of antigen inhaled during infection. American Journal of Veterinary Research: in press.
17. Gogolewski RP, Schaefer DC, Wasson SK, Corbeil RR and Corbeil LB (1989). Pulmonary persistence of Haemophilus somnus in the presence of specific antibody. Journal of Clinical Microbiology 27: 1767-1774.
18. Hendricks DA, Baradaran K, McIntosh K and Patterson JL (1987). Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. Journal of General Virology 68: 1705-1714.
19. Johnson TR and Graham BS (1999). Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. Journal of Virology 73: 8485-8495.
20. Juntti H, Kokkonen J, Dunder T, Renko M, Niinimaki A and Uhari M (2003). Association of an early respiratory syncytial virus infection and atopic allergy. Allergy 58: 878-884.
21. Kalina WV, Woolums AR, Berghaus RD and Gershwin LJ (2004). Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle. Vaccine 29: 1465-1474.
22. Kalina WV, Anderson ML and Gershwin LJ (2006). Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production. Comparative Immunology Microbiology and Infectious Diseases 29: 138-156.
23. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K and Parrott RH (1969). Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89: 422-434.
24. Kimman TG, Westenbrink F, Schreuder BE and Straver PJ (1987). Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies. Journal of Clinical Microbiology 25: 1097-1106.
25. Kimman TG, Sol J, Westenbrink F and Straver PJ (1989). A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine. Veterinary Quarterly 11: 250-253.
26. LeBlanc PH, Baker JC, Gray PR, Robinson NE and Derksen FJ (1991). Effects of bovine respiratory syncytial virus on airway function in neonatal calves. American Journal of Veterinary Research 52: 1401-1406.
27. Mapletoft JW, Oumouna M, Townsend HG, Gomis S, Babiuk LA and van Drunen Littel-van den Hurk S (2006). Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus. Virology 353: 316-323.
28. McInnes E, Sopp P, Howard CJ and Taylor G (1999). Phenotypic analysis of local cellular responses in calves infected with bovine respiratory syncytial virus. Immunology 96: 396-403.
29. Meyer G, Deplanche M and Schelcher F (2007). Human and bovine respiratory syncytial virus vaccine research and development. Comparative Immunology Microbiology and Infectious Diseases: in press.
30. Olchowy TW, Gershwin LJ and Dean DF (1995). Allergic rhinitis in a herd of cattle. Journal of the American Veterinary Medical Association 207: 1211-1214.
31. Openshaw PJ, Culley FJ and Olszewska W (2001). Immuno-pathogenesis of vaccine-enhanced RSV disease. Vaccine 20 (suppl. 1): S27-S31.
32. Otto P, Elschner M, Reinhold P, Kcihler H, Streckert HJ, Philippou S, Werchau H and Morgenroth K (1996). A model for respiratory syncytial virus (RSV) infection based on experimental aerosol exposure with bovine RSV in calves. Comparative Immunology Microbiology and Infectious Diseases 19: 85-97.
33. Roman M, Calhoun WJ, Hinton KL, Avendano LF, Simon V, Escobar AM, Gaggero A and Diaz PV (1997). Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. American Journal of Respiratory and Critical Care Medicine 156: 190-195.
34. Samal SK and Zamora M (1991). Nucleotide sequence analysis of a matrix and small hydrophobic protein dicistronic mRNA of bovine respiratory syncytial virus demonstrates extensive sequence divergence of the small hydrophobic protein from that of human respiratory syncytial virus. Journal of General Virology 72: 1715-1720.
35. Schreiber P, Matheise JP, Dessy F, Heimann M, Letesson JJ, Coppe P and Collard A (2000). High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine. Journal of Veterinary Medicine B Infectious Diseases and Veterinary Public Health 47: 535-550.
36. Stewart RS and Gershwin LJ (1989). Role of IgE in the pathogenesis of bovine respiratory syncytial virus in sequential infections in vaccinated and nonvaccinated calves. American Journal of Veterinary Research 50: 349-355.
37. Taylor G, Thomas LH, Furze JM, Cook RS, Wyld SG, Lerch R, Hardy R and Wertz GW (1997). Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions. Journal of General Virology 78: 3195-3206.
38. Trudel M, Nadon F, Simard C, Be;langer F, Alain R, Seguin C and Lussier G (1989). Comparison of caprine, human and bovine strains of respiratory syncytial virus. Archives of Virology 107: 141-149.
39. Valarcher JF and Taylor G (2007). Bovine respiratory syncytial virus infection. Veterinary Research 38: 153-180.
40. Valarcher JF, Schelcher F and Bourhy H (2000). Evolution of bovine respiratory syncytial virus. Journal of Virology 74: 10714-10728.
41. Van der Poel WH, Brand A, Kramps JA and Van Oirschot JT (1994). Respiratory syncytial virus infections in human beings and in cattle. Journal of Infection 29: 215-228.
42. van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N and Kovacs-Nolan J (2007). Immunopathology of RSV infection: prospects for developing vaccines without this complication. Reviews in Medical Virology 17: 5-34.
43. Welliver RC, Wong DT, Sun M, Middleton Jr E, Vaughan RS and Ogra PL (1981). The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. New England Journal of Medicine 305: 841-846.
44. West K, Bogdan J, Hamel A, Nayar G, Morley PS, Haines DM and Ellis JA (1998). A comparison of diagnostic methods for the detection of bovine respiratory syncytial virus in experimental clinical specimens. Canadian Journal of Veterinary Research 62: 245-250.
45. Woolums AR, Singer RS, Boyle GA and Gershwin LJ (1999a). Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV. Vaccine 17: 1293-1297.
46. Woolums AR, Anderson ML, Gunther RA, Schelegle ES, LaRochelle DR, Singer RS, Boyle GA, Friebertshauser KE and Gershwin LJ (1999b). Evaluation of severe disease induced by aerosol inoculation of calves with bovine respiratory syncytial virus. American Journal of Veterinary Research 60: 473-480.
47. Zimmer G, Rohn M, McGregor GP, Schemann M, Conzelmann KK and Herrler G (2003). Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus. Journal of Biological Chemistry 278: 46854-46861.